dr. dogan on updated who classifications in dlbcl
Published 7 years ago • 261 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:24
dr. ruan on classifying t-cell lymphomas
-
8:21
risk-based therapy for dlbcl
-
1:44
updates in the who classification for lymphoma and how this may impact clinical practice
-
4:00
maintenance therapy for dlbcl
-
1:22
dr. cohen on the evolution of antibodies in lymphoma
-
2:44
cns invasion in b-cell lymphoma: a novel diagnostic and prognostic tool
-
2:03
the next generation of novel agents in development for aggressive b-cell lymphoma
-
0:46
dr. goodman on the need for molecular subtyping in t-cell lymphomas
-
4:41
answers from the experts: cutaneous b-cell lymphoma variants
-
2:19
session highlights: autosct in t-cell lymphoma, classification updates and fertility preservation
-
5:08
updates on novel agents in development for aggressive b-cell lymphoma
-
0:13
johns hopkins medicine researchers advance understanding of why cell parts look the way they do
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
1:25
dr. kurtz on the clinical utility of cell-free dna in lymphoma
-
3:11
cd47-targeting antibody: targeting the source of non-hodgkin lymphoma
-
5:12
the current standard of care in advanced stage hl
-
1:21
the future of lymphoma treatment – combining new therapies with molecular diagnosis
-
4:32
overall survival in patients with chl who progress after autosct in the era of novel agents
-
2:11
understanding the good bacteria